GTS Securities’s Veracyte VCYT Stock Holding History

GTS Securities’s Portfolio VCYT Stock Details VCYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,526	Closed	-$361K	–	1817
2025 Q3	$361K	Buy	+10,526	New	+$302K	0.01%	919

Other funds holding VCYT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

GTS Securities's VCYT Position: Q4 2025 in Review

GTS Securities sold out of Veracyte (VCYT) in Q4 2025, closing a stake of 10,526 shares — an estimated $361K sold.

GTS Securities first reported a position in VCYT in Q3 2025 and held it in 1 quarter. The position peaked at $361K in Q3 2025. 329 funds tracked by Wall St. Rank hold VCYT as of Q4 2025.

GTS Securities reported no remaining Veracyte position as of Q4 2025 after selling out during the quarter.
GTS Securities sold 10,526 Veracyte shares in Q4 2025, an estimated $361K.
GTS Securities first reported a position in Veracyte in Q3 2025 and held it in 1 quarter.
GTS Securities's Veracyte position peaked at $361K in Q3 2025.
329 funds tracked by Wall St. Rank held Veracyte as of Q4 2025.

Based on GTS Securities's 13F filing for Q4 2025, filed 13 Feb 2026.